DM Medical Oncology (Breast & Gynaecological Cancer and Lung Cancer) — Thesis Title List
45 titles · instant objectives
-
001
Clinico-pathological profile, receptor status and treatment outcome of breast cancer in young women (below 40 years)
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
002
Pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer and its correlation with molecular subtype
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
003
Cardiotoxicity of trastuzumab and anthracycline-based chemotherapy in HER2-positive breast cancer: incidence and risk factors
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
004
Outcome of platinum-based chemotherapy in epithelial ovarian cancer and predictors of platinum resistance
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
005
Concurrent chemoradiation in locally advanced carcinoma cervix: toxicity profile and treatment response
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
006
Efficacy and toxicity of CDK4/6 inhibitors with endocrine therapy in hormone receptor-positive metastatic breast cancer: a real-world study
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
007
Clinico-pathological profile and EGFR/ALK mutation status in non-small cell lung cancer and response to targeted therapy
Lung Cancer
Prospective observational study
Prospective Study
-
008
Clinical profile and outcome of lung cancer in never-smokers compared with smokers
Lung Cancer
Prospective comparative study
Comparative Study
-
009
Response and survival with immune checkpoint inhibitors in advanced non-small cell lung cancer: a single-centre experience
Lung Cancer
Prospective observational study
Prospective Study
-
010
Clinical profile, treatment and survival in small cell lung cancer at a tertiary care centre
Lung Cancer
Retrospective record-based study
Descriptive Study
-
011
Quality of life and symptom burden in patients with advanced lung cancer on systemic therapy
Lung Cancer
Prospective observational study
Cross-sectional Study
-
012
Ovarian function and fertility preservation practices in young women receiving chemotherapy
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
013
Clinical profile and outcome of triple-negative breast cancer and role of platinum-based neoadjuvant chemotherapy
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
014
Pathological complete response with neoadjuvant dual HER2 blockade in HER2-positive early breast cancer: a real-world study
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
015
Prevalence and clinicopathological features of HER2-low breast cancer compared with HER2-zero breast cancer
Breast & Gynaecological Cancer
Retrospective record-based study
Descriptive Study
-
016
Prevalence of germline BRCA1 and BRCA2 mutations in triple-negative breast cancer and epithelial ovarian cancer
Breast & Gynaecological Cancer
Hospital-based cross-sectional study
Cross-sectional Study
-
017
Progression-free survival and toxicity of PARP inhibitor maintenance in BRCA-mutated advanced ovarian cancer
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
018
Weekly versus three-weekly paclitaxel-carboplatin in advanced epithelial ovarian cancer: response and toxicity
Breast & Gynaecological Cancer
Prospective comparative study
Comparative Study
-
019
Response and toxicity of pembrolizumab with chemotherapy in recurrent or metastatic carcinoma cervix
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
020
Molecular classification of endometrial carcinoma by mismatch repair and p53 status and its correlation with outcome
Breast & Gynaecological Cancer
Retrospective record-based study
Descriptive Study
-
021
Adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
022
Clinicopathological profile and treatment outcome of male breast cancer
Breast & Gynaecological Cancer
Retrospective record-based study
Descriptive Study
-
023
Real-world outcomes and patterns of progression with first-line osimertinib in EGFR-mutant non-small cell lung cancer
Lung Cancer
Prospective observational study
Prospective Study
-
024
Response and toxicity of low-dose nivolumab with chemotherapy in advanced non-small cell lung cancer
Lung Cancer
Prospective observational study
Prospective Study
-
025
Concordance between plasma ctDNA and tissue testing for EGFR mutations in advanced non-small cell lung cancer
Lung Cancer
Prospective observational study
Diagnostic Study
-
026
Outcome of alectinib in ALK-rearranged non-small cell lung cancer at a tertiary care centre
Lung Cancer
Prospective observational study
Prospective Study
-
027
Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion in lung cancer
Lung Cancer
Prospective comparative study
Comparative Study
-
028
CT-defined sarcopenia and its association with chemotherapy toxicity in advanced lung cancer
Lung Cancer
Prospective observational study
Prospective Study
-
029
Prior empirical antitubercular treatment and diagnostic delay in patients with lung cancer
Lung Cancer
Hospital-based cross-sectional study
Cross-sectional Study
-
030
Clinical profile and outcome of thymic epithelial tumours
Lung Cancer
Retrospective record-based study
Descriptive Study
-
031
Prevalence of ESR1 mutations on plasma circulating tumour DNA at progression on aromatase inhibitor plus CDK4/6 inhibitor in hormone receptor-positive metastatic breast cancer
Breast & Gynaecological Cancer
Hospital-based cross-sectional study
Cross-sectional Study
-
032
Treatment sequencing and outcomes after progression on CDK4/6 inhibitors in hormone receptor-positive HER2-low metastatic breast cancer
Breast & Gynaecological Cancer
Retrospective record-based study
Descriptive Study
-
033
Response and toxicity of induction chemotherapy followed by concurrent chemoradiation in locally advanced carcinoma cervix
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
034
Stage at diagnosis, prior screening history and treatment delays among women with carcinoma cervix at a tertiary cancer centre
Breast & Gynaecological Cancer
Hospital-based cross-sectional study
Cross-sectional Study
-
035
Discordance in HER2 status between primary tumour and metastatic biopsy in breast cancer and its effect on eligibility for HER2-low directed therapy
Breast & Gynaecological Cancer
Hospital-based cross-sectional study
Cross-sectional Study
-
036
Uptake, toxicity and early outcomes of perioperative and adjuvant systemic therapy in resectable non-small cell lung cancer
Lung Cancer
Prospective observational study
Prospective Study
-
037
Frequency of uncommon EGFR mutations and response to tyrosine kinase inhibitors in non-small cell lung cancer at a tertiary care centre
Lung Cancer
Retrospective record-based study
Descriptive Study
-
038
Prevalence of KRAS G12C, ROS1, RET and MET exon 14 alterations on next-generation sequencing in EGFR- and ALK-negative non-small cell lung cancer
Lung Cancer
Hospital-based cross-sectional study
Cross-sectional Study
-
039
Durvalumab consolidation after concurrent chemoradiation in unresectable stage III non-small cell lung cancer: progression-free survival and pneumonitis
Lung Cancer
Prospective observational study
Prospective Study
-
040
Response, progression-free survival and neutropenia with eribulin in pretreated metastatic breast cancer: triple-negative versus hormone receptor-positive disease
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
041
Low-dose lapatinib with capecitabine in trastuzumab-pretreated HER2-positive metastatic breast cancer: response, toxicity and cost
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
042
Pattern and timing of recurrence by molecular subtype after curative treatment of non-metastatic breast cancer
Breast & Gynaecological Cancer
Retrospective record-based study
Descriptive Study
-
043
Tumour budding and its association with nodal status, molecular subtype and pathological response to neoadjuvant chemotherapy in breast carcinoma
Breast & Gynaecological Cancer
Prospective observational study
Prospective Study
-
044
Uptake and yield of visual inspection with acetic acid and clinical breast examination among community health workers offered workplace screening
Breast & Gynaecological Cancer
Cross-sectional study
Cross-sectional Study
-
045
Baseline pulmonary function and DLCO as predictors of radiation pneumonitis after concurrent chemoradiation in stage III non-small cell lung cancer
Lung Cancer
Prospective observational study
Prospective Study